Clinico-pathological observation of Gaucher disease type I
DOI:
https://doi.org/10.26641/1997-9665.2024.3.77-81Keywords:
Gaucher disease, autopsy, microscopic examinationAbstract
Background. Gaucher disease is one of the most common autosomal recessive lysosomal storage diseases which characterize by accumulation of glucosylceramide in the macrophages what is leading to the formation of Gaucher cells in the bone marrow, liver, spleen, brain and other organs with the occurrence of clinical manifestations of varying severity and age of onset. Objective. To describe local and systemic changes in the organs at Gaucher disease type I for optimization of intravital and postmortem diagnostics. Material and methods. A description of autopsy case of Gaucher disease type I. Macroscopic and histological examination were performed using standard processing. Results. In a 24-year-old woman with clinically diagnosed in childhood Gaucher disease type I, who died from liver and kidney failure, pathological examination revealed the formation of characteristic Gaucher cells in the liver with hepatomegaly, fibrosis and reorganization of the liver tissue, in mesenteric lymph nodes, bones, pia mater. The disease was complicated by bilateral hydrothorax, ascites, edema-swelling of the brain tissue, small multiple acute erosions of the stomach and duodenum mucosa with minor acute gastric bleeding, anemia and thrombocytopenia. Conclusion. In the presented observation, in spite of the early diagnostics of Gaucher disease, the patient did not receive appropriate therapy, what led to the development of severe complications and death at young age.
References
- Platt FM, d'Azzo A, Davidson BL, Neufeld EF, Tifft CJ. Lysosomal storage diseases. Nat Rev Dis Primers. 2018;4(1):27. doi: 10.1038/s41572-018-0025-4.
- Nalysnyk L, Rotella P, Simeone JC, Hamed A, Weinreb N. Gaucher disease epidemiology and natural history: a comprehensive review of the literature. Hematology. 2017;22(2):65-73. doi: 10.1080/10245332.2016.1240391. Epub 2016 Oct 20. PMID: 27762169.
- Wang M, Li F, Zhang J, Lu C, Kong W. Global Epidemiology of Gaucher Disease: an Updated Systematic Review and Meta-analysis. J Pediatr Hematol Oncol. 2023;45(4):181-188. doi: 10.1097/MPH.0000000000002506. Epub 2022 Jul 22. PMID: 35867706; PMCID: PMC10115488.
- Hruska KS, LaMarca ME, Scott CR, Sidransky E. Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA). Hum Mutat. 2008;29(5):567-583. doi: 10.1002/humu.20676. PMID: 18338393.
- Sidransky E. Gaucher disease: insights from a rare Mendelian disorder. Discov Med. 2012;14(77):273-281. PMID: 23114583; PMCID: PMC4141347.
- Grabowski GA, Zimran A, Ida H. Gaucher disease types 1 and 3: Phenotypic characterization of large populations from the ICGG Gaucher Registry. Am J Hematol. 2015;90(1):12-18. doi: 10.1002/ajh.24063. PMID: 26096741.
- Rosenbloom BE, Weinreb NJ. Gaucher disease: a comprehensive review. Crit Rev Oncog. 2013;18(3):163-175. doi: 10.1615/critrevoncog.2013006060. PMID: 23510062.
- Mehta A, Belmatoug N, Bembi B, Deegan P, Elstein D, Göker-Alpan Ö, Lukina E, Mengel E, Nakamura K, Pastores GM, Pérez-López J, Schwartz I, Serratrice C, Szer J, Zimran A, Di Rocco M, Panahloo Z, Kuter DJ, Hughes D. Exploring the patient journey to diagnosis of Gaucher disease from the perspective of 212 patients with Gaucher disease and 16 Gaucher expert physicians. Mol Genet Metab. 2017;122(3):122-129. doi: 10.1016/j.ymgme.2017.08.002. Epub 2017 Aug 4. PMID: 28847676.
- Mistry PK, Cappellini MD, Lukina E, Ozsan H, Mach Pascual S, Rosenbaum H, Helena Solano M, Spigelman Z, Villarrubia J, Watman NP, Massenkeil G. A reappraisal of Gaucher disease-diagnosis and disease management algorithms. Am J Hematol. 2011;86(1):110-115. doi: 10.1002/ajh.21888. PMID: 21080341; PMCID: PMC3058841.
- Mistry PK, Sadan S, Yang R, Yee J, Yang M. Consequences of diagnostic delays in type 1 Gaucher disease: the need for greater awareness among hematologists-oncologists and an opportunity for early diagnosis and intervention. Am J Hematol. 2007;82(8):697-701. doi: 10.1002/ajh.20908. PMID: 17492645.
- Gonzalez DE, Turkia HB, Lukina EA, Kisinovsky I, Dridi MF, Elstein D, Zahrieh D, Crombez E, Bhirangi K, Barton NW, Zimran A. Enzyme replacement therapy with velaglucerase alfa in Gaucher disease: Results from a randomized, double-blind, multinational, Phase 3 study. Am J Hematol. 2013;88(3):166-171. doi: 10.1002/ajh.23381. Epub 2013 Feb 6. PMID: 23386328.
- Hughes DA, Gonzalez DE, Lukina EA, Mehta A, Kabra M, Elstein D, Kisinovsky I, Giraldo P, Bavdekar A, Hangartner TN, Wang N, Crombez E, Zimran A. Velaglucerase alfa (VPRIV) enzyme replacement therapy in patients with Gaucher disease: Long-term data from phase III clinical trials. Am J Hematol. 2015;90(7):584-591. doi: 10.1002/ajh.24012. PMID: 25801797; PMCID: PMC4654249.
- Mistry PK, Deegan P, Vellodi A, Cole JA, Yeh M, Weinreb NJ. Timing of initiation of enzyme replacement therapy after diagnosis of type 1 Gaucher disease: effect on incidence of avascular necrosis. Br J Haematol. 2009;147(4):561-570. doi: 10.1111/j.1365-2141.2009.07872.x. Epub 2009 Sep 3. PMID: 19732054; PMCID: PMC2774157.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
The authors reserve the right to authorship of their work and transfer to the Journal the right to the first publication of this work under the terms of a license Creative commons Attribution 4.0 International (CC BY 4.0), which allows other people to freely distribute the published work with a mandatory reference to the authors of the original work and the first publication of the work in this journal.By submitting a manuscript to the editorial office of the Journal ‘Morphologia’ authors agree to transfer the rights to protect and use the manuscript (all supplemental materials, particularly protected objects such as photos, drawings, diagrams, tables, etc.), including the reproduction in the press and distribution via the Internet; translation of the manuscript into any language; export and import of journal copies with the Authors’ article in order to make it available for public. Authors convey the rights mentioned above to the editorial office without any temporal or territorial limitation all over the world.
The Authors guarantee that they have the exclusive rights to use the material transferred to editorial office. Editors are not responsible to third parties for contraventions of warranty given by the Authors. The considered rights are transferred to the editorial office since the moment when the current issue is signed for publishing. Reproduction of materials published in the Journal by other individuals and legal entities is possible only with the consent of Editorial office, with the obligatory indication of the full bibliographic reference of the primary publication. The Authors reserve the right to use the published material, its fragments and parts for teaching materials, oral presentations, dissertation thesis prepararion with obligatory bibliographic citation of the original paper. Electron copy of the published article, downloaded from official journal web-site in .pdf format may be put by authors on the official web-site of their institutions, any other official resources with open access.
